Jeff Maris Email

Key Account Manager OEM and Laboratory Sales . SOL-MILLENNIUM Medical Group

Current Roles

Employees:
183
Revenue:
$45.9M
About
SOL-MILLENNIUM Medical Group is a global healthcare company dedicated to the research and development, manufacture and distribution of high quality medical devices. Originally a leading producer of plastic moulds for the global medical industry - we were the first syringe mould producer in China and now supply over 60% of China's syringe mould needs, as well exporting globally. This background sets the stage for our current focus in developing high quality and affordable safety medical devices that support best clinical practice – whilst also protecting healthcare workers (and their patients) from the risks associated with needlestick injury and accidental blood exposure. We currently manufacture a range of safety syringes, needles and blood collection devices under the SOL-CARE and SOL-GUARD brands. We also produce syringes and needles for the veterinary industry under the SOL-VET line of products, as well as an extensive range of standard (non-safety) needles and syringes. We have a rich pipeline of new product innovation, and ambitious plans to grow our brands and our business. Close collaboration with frontline healthcare professionals is critical to the way we work – by sharing knowledge and ideas together we continuously improve our offer and work toward our goal of ‘Building a Heathier Tomorrow'.   SOL-MILLENNIUM has global presence with sales and marketing offices in Brazil, Poland and USA and a European R&D Centre, based in Switzerland.
SOL-MILLENNIUM Medical Group Address
311 S Wacker Drive
Chicago, IL
United States
SOL-MILLENNIUM Medical Group Email

Past Companies

SOL-MILLENNIUM Medical GroupKey Account Manager of OEM and Laboratory Sales
SOL-MILLENNIUM Medical GroupSales Manager of Corporate/ Specialty Accounts
Ironwood Industries, Inc.Sales Engineer/ Business Development

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.